Main Article Content
adolescents, asthma, GAN, ISAAC, prevalence
Introduction and objectives: Asthma is the most prevalent chronic disease in childhood. However, the latest data on its prevalence in Spain are from Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC), 2004. The objective of our study was to assess the prevalence of asthma symptoms, severity and diagnosis in the paediatric population aged between 13 and 14 years in the province of Salamanca.
Material and methods: Cross-sectional multicentre study carried out in 2017–2018 in 13- and 14-year-old school children in the province of Salamanca as a centre participating in of the Global Asthma Network(GAN) Phase I. The standardised validated written questionnaire and that directed by a video was administered; it was self-completed by the pupils.
Results: A total of 3485 questionnaires were completed, and the pupils’ participation rate was 95.01%. Among the total, 25.7% indicated having had wheeze ever (20.7% in the video questionnaire); 14.7% indicated having had wheeze in the past 12 months (11.3% in the video questionnaire). The prevalence of current wheeze that limited speech was 3.9% (7.5% in the video questionnaire) and the current prevalence of severe wheeze was 6.5%. Regarding asthma diagnosis, 19.7% of the sample answered that they had had asthma ever, whilst 14.0% referred to having physician-diagnosed asthma. The agreement between the written questionnaire and that directed by video was acceptable for the questions of wheeze ever (Cohen Kappa index [k] = 0.53) and current wheeze (k = 0.42).
Conclusions: The prevalence of current asthma (wheeze in the past 12 months) in the population aged 13 and 14 years in the province of Salamanca is higher compared with that presented in 2004 in Spain, but similar to that described at the world level (low-moderate level), according to the ISAAC Phase III studies.
2. Ferrante G, La Grutta S. The burden of pediatric asthma. Front Pediatr. 2018;6:186. 10.3389/fped.2018.00186
3. Jenkins MA, Clarke JR, Carlin JB, Robertson CF, Hopper JL, Dalton MF, et al. Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma. Int J Epidemiol. 1996;25:609–16. 10.1093/ije/25.3.609
4. Asher MI, Stewart AW, Mallol J, Montefort S, Lai Christopher KW, Aït-Khaled N, et al. Which population level environmental factors are associated with asthma, rhino-conjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One. Respir Res. 2010;11:8. 10.1186/1465-9921-11-8
5. Shaw RA, Crane J, Pearce N, Burgess CD, Bremner P, Woodman K, et al. Comparison of a video questionnaire* with the IUATLD written questionnaire for measuring asthma prevalence. Clin Exp Allergy. 1992;22:561–8. 10.1111/j.1365-2222.1992.tb00166.x
6. Mallol J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A. The International Study of Asthma and Allergies in Childhood (ISAAC) phase three: A global synthesis. Allergol Immunopathol (Madr). 2013;41:73–85. 10.1016/j.aller.2012.03.001
7. García-Marcos L, Blanco Quirós A, García Hernández G, Guillén-Grima F, González Díaz C, Carvajal Ureña I, et al. Stabilization of asthma prevalence among adolescents and increase among schoolchildren (ISAAC phases I and III) in Spain. Allergy Eur J Allergy Clin Immunol. 2004;59:1301–7. 10.1111/j.1398-9995.2004.00562.x
8. García-Marcos L, Batllés-Garrido J, Blanco-Quirós A, García-Hernández G, Guillén-Grima F, González-Díaz C, et al. Influence of two different geo-climatic zones on the prevalence and time trends of asthma symptoms among Spanish adolescents and schoolchildren. Int J Biometeorol. 2009;53:53–60. 10.1007/s00484-008-0190-3
9. Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S, et al. Global variation in the prevalence and severity of asthma symptoms: Phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2009;64:476–83. 10.1136/thx.2008.106609
10. López P, Gandarillas AM, Díez L, Ordobás M. Evolución de la prevalencia de asma y factores socio-demográficos y de salud asociados en población de 18 a 64 años de la Comunidad de Madrid (1996–2013) [Evolution of the prevalence of asthma and associated sociodemographic and health factors in the population aged 18 to 64 in the Community of Madrid (1996–2013)]. Rev Esp Salud Pública. 2017;91:1–14. Spanish.
11. Asher MI, García-Marcos L, Pearce NE, Strachan DP. Trends in worldwide asthma prevalence. Eur Respir J. 2020;56:2002094. 10.1183/13993003.02094-2020
12. Ellwood P, Ellwood E, Rutter C, Perez-Fernandez V, Morales E, García-Marcos L, et al. Global Asthma Network phase I surveillance: Geographical coverage and response rates. J Clin Med. 2020;9:3688. 10.3390/jcm9113688
13. Remes ST, Pekkanen J, Remes K, Salonen RO. In search of childhood asthma: Questionnaire, tests of bronchial hyperresponsiveness, and clinical evaluation. Thorax. 2002;57:120–6. 10.1136/thorax.57.2.120
14. Carvajal-Ureña I, García-Marcos L, Busquets-Monge R, Morales M, García N, Batlles-Garrido J, et al. Variaciones geográficas en la prevalencia de síntomas de asma en los niños y adolescentes españoles. International Study of Asthma and Allergies in Childhood (ISAAC) fase III España [Geographic variations in the prevalence of asthma symptoms in Spanish children and adolescents. International Study of Asthma and Allergies in Childhood (ISAAC) phase III Spain]. Arch Bronconeumol. 2005;41:659–66. Spanish. 10.1016/S0300-2896(05)70721-3
15. Dubovyi A, Chelimo C, Schierding W, Bisyuk Y, Camargo CA, Grant CC. A systematic review of asthma case definitions in 67 birth cohort studies. Paediatr Respir Rev. 2021;37:89–98. 10.1016/j.prrv.2019.12.005
16. Peat JK, Toelle BG, Marks GB, Mellis CM. Continuing the debate about measuring asthma in population studies. Thorax. 2001;56:406–11. 10.1136/thorax.56.5.406
17. Álvarez F, García M. Asma: Concepto, fisiopatología, diagnóstico y clasificación [Asthma: concept Concept, pathophysiology, diagnosis and classification]. Ped Integr. 2021;25:56–66. Spanish.
18. López-Silvarrey A, González FJ, Paz JJ, Pérez TR, Valdés I, Castro A. Prevalencia de síntomas de asma y rinitis en la población de A Coruña [Prevalence of asthma and rhinitis symptoms in the population of A Coruña]. An Pediatr. 2007;66:146–53. Spanish. 10.1157/13098932
19. Ellwood P, Asher MI, Billo NE, Bissell K, Chiang CY, Ellwood EM, et al. The Global Asthma Network rationale and methods for phase I global surveillance: Prevalence, severity, management and risk factors. Eur Respir J. 2017;49:1601–5. 10.1183/13993003.01605-2016
20. The global asthama network manual for global surveillance: Prevalence, severity and risk factors [Internet]. [cited 2016 Feb 22]. Available from: http://globalasthmanetwork.org/surveillance/manual/manual.php
21. Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW, ISAAC Steering Committee. The International Study of Asthma and Allergies in Childhood (ISAAC): Phase three rationale and methods. Int J Tuberc Lung Dis. 2005;9:10–16.
22. Amorim AJ, Daneluzzi JC. Prevalence of asthma in school-age children. J Pediatr (Rio J). 2001;77:197–202. 10.2223/JPED.206
23. Lai CK, Chan JK, Chan A, Wong G, Ho A, Choy D, et al. Comparison of the ISAAC video questionnaire (AVQ 3.0) with the ISAAC written questionnaire for estimating asthma associated with bronchial hyperreactivity. Clin Exp Allergy. 1997;27:540–5. 10.1111/j.1365-2222.1997.tb00742.x
24. Aguinaga I, Arnedo A, Bellido J, Guillén F, Suárez-Varela MM. Prevalencia de sintomas relacionados con el asma en niños de 13-14 años de 9 poblaciones españolas. Estudio ISAAC (International Study of Asthma and Allergies in Childhood) [Prevalence of asthma-related symptoms in children aged 13-14 years from 9 Spanish populations. ISAAC study (International Study of Asthma and Allergies in Childhood)]. Med Clin. 1999;112:171–5. Spanish.